Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Overview of attention for article published in Molecular Cancer, August 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 94 Dimensions

Readers on

mendeley: 84 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Methods and compositions for treatment of BRAF mutant cancers

Grant US-11590133-B2

United States of America

MEANS AND METHODS FOR IDENTIFYING A PATIENT HAVING A BRAF-POSITIVE CANCER AS A NON-RESPONDE…

Grant EP-3169797-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.